PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 201 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $322,000 | -6.9% | 8,643 | -23.4% | 0.13% | -11.1% |
| Q4 2016 | $346,000 | -39.2% | 11,278 | +32.9% | 0.14% | -43.8% |
| Q3 2016 | $569,000 | +17.3% | 8,488 | -47.9% | 0.26% | +18.0% |
| Q2 2016 | $485,000 | +2.5% | 16,288 | +1.2% | 0.22% | +2.8% |
| Q1 2016 | $473,000 | -26.9% | 16,098 | +95.1% | 0.21% | -25.4% |
| Q4 2015 | $647,000 | +6.4% | 8,253 | +2.4% | 0.28% | +7.2% |
| Q3 2015 | $608,000 | +32.5% | 8,063 | +105.1% | 0.26% | +23.9% |
| Q2 2015 | $459,000 | +85.8% | 3,931 | +276.2% | 0.21% | +79.0% |
| Q1 2015 | $247,000 | – | 1,045 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |